Evolution of the Average Target: RH

Evolution of the Target Price: RH

Changes in Analyst Recommendations: RH

af850da8857b0765651ec292.N52VogxQ9ZjhCeCChPJS7mHlyIKr682LFw542YS-8EM.UNnW630cp_CIWa3G7rZmpBWQgrOboIrlXFcXv7TpwRBg8PrbbTq9zYoklw~4450452c6941df2a5e91c4118f41028a
05:22pm UBS Adjusts Price Target on RH to $154 From $155, Keeps Neutral Rating MT
04:30pm BofA Securities Adjusts RH Price Target to $114 From $156, Maintains Underperform Rating MT
07-08 Goldman Sachs Upgrades RH to Neutral From Sell, Lifts Price Target to $155 From $86 MT
06-09 RH Q1 Unlikely to Show Business Inflection, UBS Says MT
06-09 UBS Adjusts Price Target on RH to $155 From $160, Maintains Neutral Rating MT
04-01 Guggenheim Lowers Price Target on RH to $200 From $275, Keeps Buy Rating MT
04-01 RH Facing Near-Term Challenges From Execution, Supply Chain Issues, Morgan Stanley Says MT
04-01 Morgan Stanley Lowers Price Target on RH to $240 From $275, Keeps Overweight Rating MT
12-19 JPMorgan Cuts Price Target on RH to $225 From $275, Maintains Overweight Rating MT
12-12 Stifel Downgrades RH to Hold From Buy, Adjusts Price Target to $165 From $320 MT
02/10/25 William Blair Downgrades RH to Market Perform From Outperform MT
12/09/25 Telsey Advisory Downgrades RH to Market Perform From Outperform, Adjusts Pt to $220 From $255 MT
24/06/25 RH Shares Fall After Goldman Sachs Downgrade MT
24/06/25 Goldman Sachs Downgrades RH to Sell From Neutral, Adjusts Price Target to $179 From $199 MT
05/06/25 UBS Adjusts RH Price Target to $215 From $235, Maintains Neutral Rating MT
14/05/25 BofA Securities Adjusts Price Target on RH to $172 From $144 MT
07/04/25 RH Cash Flow, Demand Guidance Eases Tariff Concerns, Wedbush Says MT
03/04/25 RH Earnings Troubles Exacerbated by Trump Tariffs, Wedbush Says; Shares Down Pre-Bell MT
03/04/25 Wedbush Adjusts RH Price Target to $250 From $350, Maintains Outperform Rating MT
03/04/25 UBS Adjusts Price Target on RH to $235 From $250, Keeps Neutral Rating MT
26/03/25 RH Could See Solid Sales, Soft Margins for Fiscal Q4, Wedbush Says MT
26/03/25 BofA Securities Cuts RH Price Target to $410 From $510, Maintains Buy Rating MT
26/03/25 Wedbush Cuts Price Target on RH to $350 From $500, Keeps Outperform Rating MT
21/03/25 UBS Adjusts Price Target on RH to $250 From $440, Keeps Neutral Rating MT
30/01/25 Goldman Sachs Upgrades RH to Neutral From Sell, Raises Price Target to $374 From $261 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+32.86%
+10.78%
-6.31%
+36.04%
+9.57%
+37.53%
+32.24%
+26.73%
+10.33%
Average +21.09%
Weighted average by Cap. +10.18%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
134.02USD
Average target price
167.12USD
Spread / Average Target
+24.70%
High Price Target
270.00USD
Spread / Highest target
+101.46%
Low Price Target
81.00USD
Spread / Lowest Target
-39.56%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
-
ESG MSCI
BB
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!